Poor Ovarian Response
26
1
1
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.7%
2 terminated out of 26 trials
83.3%
-3.2% vs benchmark
12%
3 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (26)
SIRT3 Expression in Granulosa Cells and the Levels of Follicular Fluid Metabolites Among POR Subgroups
Proteomic and Biological Characterisation of Plasma for the Study of Changes Following Ovarian Reactivation Treatment
A RCT Study on Autologous PRP Injection in Patients With POR
A RCT Study on Autologous Cell Injection Into the Ovaries of Patients With POR
Exosome-Enriched Culture Media to Enhance In Vitro Maturation and Embryo Development in Poor Ovarian Responders Undergoing IVF
Application of Platelet-rich Plasma (PRP) in Reproductive Medicine
Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial
The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)
Acupuncture for Treatment of Patients With Poor Ovarian Response
Menstrual Blood Stem Cells in Poor Ovarian Responders
Ovarian PRP Injection in Women With POR
the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR)
Improving in Vitro Fertilization in Women With Poor Ovarian Response
A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve
Novel Therapy for Poor Responders Management
Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial
Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study
A Trial Study on Acupuncture Treatment of Poor Ovarian Response
Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure
Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response